Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 183

1.

Pharmacodynamic Modeling of Bacillary Elimination Rates and Detection of Bacterial Lipid Bodies in Sputum to Predict and Understand Outcomes in Treatment of Pulmonary Tuberculosis.

Sloan DJ, Mwandumba HC, Garton NJ, Khoo SH, Butterworth AE, Allain TJ, Heyderman RS, Corbett EL, Barer MR, Davies GR.

Clin Infect Dis. 2015 Jul 1;61(1):1-8. doi: 10.1093/cid/civ195. Epub 2015 Mar 16.

2.

Effect of optional home initiation of HIV care following HIV self-testing on antiretroviral therapy initiation among adults in Malawi: a randomized clinical trial.

MacPherson P, Lalloo DG, Webb EL, Maheswaran H, Choko AT, Makombe SD, Butterworth AE, van Oosterhout JJ, Desmond N, Thindwa D, Squire SB, Hayes RJ, Corbett EL.

JAMA. 2014 Jul 23-30;312(4):372-9. doi: 10.1001/jama.2014.6493.

3.

Long term study on the effect of mollusciciding with niclosamide in stream habitats on the transmission of schistosomiasis mansoni after community-based chemotherapy in Makueni District, Kenya.

Kariuki HC, Madsen H, Ouma JH, Butterworth AE, Dunne DW, Booth M, Kimani G, Mwatha JK, Muchiri E, Vennervald BJ.

Parasit Vectors. 2013 Apr 18;6:107. doi: 10.1186/1756-3305-6-107.

4.

Optimizing outpatient serial sputum colony counting for studies of tuberculosis treatment in resource-poor settings.

Sloan DJ, Corbett EL, Butterworth AE, Mwandumba HC, Khoo SH, Mdolo A, Shani D, Kamdolozi M, Allen J, Mitchison DA, Coleman DJ, Davies GR.

J Clin Microbiol. 2012 Jul;50(7):2315-20. doi: 10.1128/JCM.00043-12. Epub 2012 May 9.

5.

Risk factors for mortality in smear-negative tuberculosis suspects: a cohort study in Harare, Zimbabwe.

Macpherson P, Dimairo M, Bandason T, Zezai A, Munyati SS, Butterworth AE, Mungofa S, Rusakaniko S, Fielding K, Mason PR, Corbett EL.

Int J Tuberc Lung Dis. 2011 Oct;15(10):1390-6. doi: 10.5588/ijtld.11.0056.

6.

Comparison of two active case-finding strategies for community-based diagnosis of symptomatic smear-positive tuberculosis and control of infectious tuberculosis in Harare, Zimbabwe (DETECTB): a cluster-randomised trial.

Corbett EL, Bandason T, Duong T, Dauya E, Makamure B, Churchyard GJ, Williams BG, Munyati SS, Butterworth AE, Mason PR, Mungofa S, Hayes RJ.

Lancet. 2010 Oct 9;376(9748):1244-53. doi: 10.1016/S0140-6736(10)61425-0.

7.

The risk and timing of tuberculosis diagnosed in smear-negative TB suspects: a 12 month cohort study in Harare, Zimbabwe.

Dimairo M, MacPherson P, Bandason T, Zezai A, Munyati SS, Butterworth AE, Mungofa S, Rusikaniko S, Fielding K, Mason PR, Corbett EL.

PLoS One. 2010 Jul 28;5(7):e11849. doi: 10.1371/journal.pone.0011849.

8.

Provider-initiated symptom screening for tuberculosis in Zimbabwe: diagnostic value and the effect of HIV status.

Corbett EL, Zezai A, Cheung YB, Bandason T, Dauya E, Munyati SS, Butterworth AE, Rusikaniko S, Churchyard GJ, Mungofa S, Hayes RJ, Mason PR.

Bull World Health Organ. 2010 Jan;88(1):13-21. doi: 10.2471/BLT.08.055467.

9.

Identifying recent Mycobacterium tuberculosis transmission in the setting of high HIV and TB burden.

Mutsvangwa J, Millington KA, Chaka K, Mavhudzi T, Cheung YB, Mason PR, Butterworth AE, Corbett EL, Lalvani A.

Thorax. 2010 Apr;65(4):315-20. doi: 10.1136/thx.2009.124891.

PMID:
20388756
10.

Interpreting tuberculin skin tests in a population with a high prevalence of HIV, tuberculosis, and nonspecific tuberculin sensitivity.

Dodd PJ, Millington KA, Ghani AC, Mutsvangwa J, Butterworth AE, Lalvani A, Corbett EL.

Am J Epidemiol. 2010 May 1;171(9):1037-45. doi: 10.1093/aje/kwq017. Epub 2010 Apr 9.

11.

Downregulation of MIP-1alpha/CCL3 with praziquantel treatment in Schistosoma haematobium and HIV-1 co-infected individuals in a rural community in Zimbabwe.

Zinyama-Gutsire R, Gomo E, Kallestrup P, Erikstrup C, Ullum H, Butterworth AE, Munyati S, Mduluza T.

BMC Infect Dis. 2009 Oct 23;9:174. doi: 10.1186/1471-2334-9-174.

12.

Diagnostic accuracy of commercial urinary lipoarabinomannan detection in African tuberculosis suspects and patients.

Mutetwa R, Boehme C, Dimairo M, Bandason T, Munyati SS, Mangwanya D, Mungofa S, Butterworth AE, Mason PR, Corbett EL.

Int J Tuberc Lung Dis. 2009 Oct;13(10):1253-9.

13.

Prevalent infectious tuberculosis in Harare, Zimbabwe: burden, risk factors and implications for control.

Corbett EL, Bandason T, Cheung YB, Makamure B, Dauya E, Munyati SS, Churchyard GJ, Williams BG, Butterworth AE, Mungofa S, Hayes RJ, Mason PR.

Int J Tuberc Lung Dis. 2009 Oct;13(10):1231-7.

14.

Use of circulating cathodic antigen strips for the diagnosis of urinary schistosomiasis.

Midzi N, Butterworth AE, Mduluza T, Munyati S, Deelder AM, van Dam GJ.

Trans R Soc Trop Med Hyg. 2009 Jan;103(1):45-51. doi: 10.1016/j.trstmh.2008.08.018. Epub 2008 Oct 31.

PMID:
18951599
15.

Schistosomiasis and infection with human immunodeficiency virus 1 in rural Zimbabwe: systemic inflammation during co-infection and after treatment for schistosomiasis.

Erikstrup C, Kallestrup P, Zinyama-Gutsire RB, Gomo E, van Dam GJ, Deelder AM, Butterworth AE, Pedersen BK, Ostrowski SR, Gerstoft J, Ullum H.

Am J Trop Med Hyg. 2008 Sep;79(3):331-7.

PMID:
18784223
16.

Reduced mortality and CD4 cell loss among carriers of the interleukin-10 -1082G allele in a Zimbabwean cohort of HIV-1-infected adults.

Erikstrup C, Kallestrup P, Zinyama-Gutsire RB, Gomo E, Butterworth AE, Pedersen BK, Ostrowski SR, Gerstoft J, Ullum H.

AIDS. 2007 Nov 12;21(17):2283-91.

PMID:
18090276
17.

HIV incidence during a cluster-randomized trial of two strategies providing voluntary counselling and testing at the workplace, Zimbabwe.

Corbett EL, Makamure B, Cheung YB, Dauya E, Matambo R, Bandason T, Munyati SS, Mason PR, Butterworth AE, Hayes RJ.

AIDS. 2007 Feb 19;21(4):483-9.

PMID:
17301567
18.

Nursing and community rates of Mycobacterium tuberculosis infection among students in Harare, Zimbabwe.

Corbett EL, Muzangwa J, Chaka K, Dauya E, Cheung YB, Munyati SS, Reid A, Hakim J, Chandiwana S, Mason PR, Butterworth AE, Houston S.

Clin Infect Dis. 2007 Feb 1;44(3):317-23. Epub 2006 Dec 29.

PMID:
17205434
19.

Human immunodeficiency virus, smoking and self-rated health in Harare, Zimbabwe.

Munyati SS, Redzo N, Dauya E, Matambo R, Makamure B, Bandason T, Butterworth AE, Gwanzura L, Rusakaniko S, Mason PR, Corbett EL.

Int J Tuberc Lung Dis. 2006 Nov;10(11):1279-85.

PMID:
17131789
20.

Morbidity in schistosomiasis: assessment, mechanisms and control.

Vennervald BJ, Ouma JH, Butterworth AE.

Parasitol Today. 1998 Oct;14(10):385-90. No abstract available.

PMID:
17040825
21.

Uptake of workplace HIV counselling and testing: a cluster-randomised trial in Zimbabwe.

Corbett EL, Dauya E, Matambo R, Cheung YB, Makamure B, Bassett MT, Chandiwana S, Munyati S, Mason PR, Butterworth AE, Godfrey-Faussett P, Hayes RJ.

PLoS Med. 2006 Jul;3(7):e238.

22.

Schistosomiasis and HIV in rural Zimbabwe: efficacy of treatment of schistosomiasis in individuals with HIV coinfection.

Kallestrup P, Zinyama R, Gomo E, Butterworth AE, van Dam GJ, Gerstoft J, Erikstrup C, Ullum H.

Clin Infect Dis. 2006 Jun 15;42(12):1781-9. Epub 2006 May 10.

PMID:
16705587
23.

Voluntary counseling and testing by nurse counselors: what is the role of routine repeated testing after a negative result?

Matambo R, Dauya E, Mutswanga J, Makanza E, Chandiwana S, Mason PR, Butterworth AE, Corbett EL.

Clin Infect Dis. 2006 Feb 15;42(4):569-71. Epub 2006 Jan 17.

PMID:
16421803
24.

Schistosomiasis and HIV-1 infection in rural Zimbabwe: effect of treatment of schistosomiasis on CD4 cell count and plasma HIV-1 RNA load.

Kallestrup P, Zinyama R, Gomo E, Butterworth AE, Mudenge B, van Dam GJ, Gerstoft J, Erikstrup C, Ullum H.

J Infect Dis. 2005 Dec 1;192(11):1956-61. Epub 2005 Oct 20.

PMID:
16267767
25.

Chronic cough in primary health care attendees, Harare, Zimbabwe: diagnosis and impact of HIV infection.

Munyati SS, Dhoba T, Makanza ED, Mungofa S, Wellington M, Mutsvangwa J, Gwanzura L, Hakim J, Nyakabau M, Mason PR, Robertson V, Rusakaniko S, Butterworth AE, Corbett EL.

Clin Infect Dis. 2005 Jun 15;40(12):1818-27. Epub 2005 May 12.

PMID:
15909272
26.

Schistosomiasis and HIV-1 infection in rural Zimbabwe: implications of coinfection for excretion of eggs.

Kallestrup P, Zinyama R, Gomo E, Butterworth AE, van Dam GJ, Erikstrup C, Ullum H.

J Infect Dis. 2005 Apr 15;191(8):1311-20. Epub 2005 Mar 9.

PMID:
15776378
27.

Regression of hepatosplenomegaly in Kenyan school-aged children after praziquantel treatment and three years of greatly reduced exposure to Schistosoma mansoni.

Vennervald BJ, Booth M, Butterworth AE, Kariuki HC, Kadzo H, Ireri E, Amaganga C, Kimani G, Kenty L, Mwatha J, Ouma JH, Dunne DW.

Trans R Soc Trop Med Hyg. 2005 Feb;99(2):150-60.

PMID:
15607341
28.

Epidemiology and morbidity of Schistosoma mansoni infection in a fishing community along Lake Albert in Uganda.

Kabatereine NB, Kemijumbi J, Ouma JH, Kariuki HC, Richter J, Kadzo H, Madsen H, Butterworth AE, Ørnbjerg N, Vennervald BJ.

Trans R Soc Trop Med Hyg. 2004 Dec;98(12):711-8.

PMID:
15485701
29.

Exposure to malaria affects the regression of hepatosplenomegaly after treatment for Schistosoma mansoni infection in Kenyan children.

Booth M, Vennervald BJ, Butterworth AE, Kariuki HC, Amaganga C, Kimani G, Mwatha JK, Otedo A, Ouma JH, Dunne DW.

BMC Med. 2004 Sep 27;2:36.

30.

Efficacy and side effects of praziquantel treatment in a highly endemic Schistosoma mansoni focus at Lake Albert, Uganda.

Kabatereine NB, Kemijumbi J, Ouma JH, Sturrock RF, Butterworth AE, Madsen H, Ornbjerg N, Dunne DW, Vennnervald BJ.

Trans R Soc Trop Med Hyg. 2003 Sep-Oct;97(5):599-603.

PMID:
15307437
31.

Micro-geographical variation in exposure to Schistosoma mansoni and malaria, and exacerbation of splenomegaly in Kenyan school-aged children.

Booth M, Vennervald BJ, Kenty L, Butterworth AE, Kariuki HC, Kadzo H, Ireri E, Amaganga C, Kimani G, Mwatha JK, Otedo A, Ouma JH, Muchiri E, Dunne DW.

BMC Infect Dis. 2004 May 17;4:13.

32.

Detailed clinical and ultrasound examination of children and adolescents in a Schistosoma mansoni endemic area in Kenya: hepatosplenic disease in the absence of portal fibrosis.

Vennervald BJ, Kenty L, Butterworth AE, Kariuki CH, Kadzo H, Ireri E, Amaganga C, Kimani G, Mwatha J, Otedo A, Booth M, Ouma JH, Dunne DW.

Trop Med Int Health. 2004 Apr;9(4):461-70.

33.

The detection of antibodies against Schistosoma mansoni soluble egg antigens (SEA) and CEF6 in ELISA, before and after chemotherapy.

Doenhoff MJ, Wheeler JG, Tricker K, Hamilton JV, Sturrock RF, Butterworth AE, Ouma JH, Mbugua GG, Kariuki C, Koech D.

Ann Trop Med Parasitol. 2003 Oct;97(7):697-709.

PMID:
14613629
34.

Associations between anti-Schistosoma mansoni and anti-Plasmodium falciparum antibody responses and hepatosplenomegaly, in Kenyan schoolchildren.

Mwatha JK, Jones FM, Mohamed G, Naus CW, Riley EM, Butterworth AE, Kimani G, Kariuki CH, Ouma JH, Koech D, Dunne DW.

J Infect Dis. 2003 Apr 15;187(8):1337-41. Epub 2003 Apr 2.

PMID:
12696017
35.

Population-based differences in Schistosoma mansoni- and hepatitis C-induced disease.

Blanton RE, Salam EA, Kariuki HC, Magak P, Silva LK, Muchiri EM, Thiongo F, Abdel-Meghid IE, Butterworth AE, Reis MG, Ouma JH.

J Infect Dis. 2002 Jun 1;185(11):1644-9. Epub 2002 May 17.

PMID:
12023771
36.

Polymorphisms in the tumor necrosis factor-alpha gene promoter may predispose to severe silicosis in black South African miners.

Corbett EL, Mozzato-Chamay N, Butterworth AE, De Cock KM, Williams BG, Churchyard GJ, Conway DJ.

Am J Respir Crit Care Med. 2002 Mar 1;165(5):690-3.

PMID:
11874815
37.

Morbidity in schistosomiasis: an update.

Ouma JH, Vennervald BJ, Butterworth AE.

Trends Parasitol. 2001 Mar;17(3):117-8. No abstract available.

PMID:
11345060
38.

Prevalence and familial aggregation of schistosomal liver morbidity in Kenya: evaluation by new ultrasound criteria.

Kariuki HC, Mbugua G, Magak P, Bailey JA, Muchiri EM, Thiongo FW, King CH, Butterworth AE, Ouma JH, Blanton RE.

J Infect Dis. 2001 Mar 15;183(6):960-6. Epub 2001 Feb 13.

PMID:
11237814
39.

Sex-dependent neutralizing humoral response to Schistosoma mansoni 28GST antigen in infected human populations.

Remoué F, Rogerie F, Gallissot MC, Guyatt HL, Neyrinck JL, Diakkhate MM, Niang M, Butterworth AE, Auriault C, Capron A, Riveau G.

J Infect Dis. 2000 May;181(5):1855-9. Epub 2000 May 15.

PMID:
10823801
40.

Cellular immune responses of a Senegalese community recently exposed to Schistosoma mansoni: correlations of infection level with age and inflammatory cytokine production by soluble egg antigen-specific cells.

Marguerite M, Gallissot MC, Diagne M, Moreau C, Diakkhate MM, Roberts M, Remoue F, Thiam A, Decam C, Rogerie F, Cottrez F, Neyrinck JL, Butterworth AE, Sturrock RF, Piau JP, Daff B, Niang M, Wolowczuk I, Riveau G, Auriault C, Capron A.

Trop Med Int Health. 1999 Aug;4(8):530-43.

41.

Development of antibody isotype responses to Schistosoma mansoni in an immunologically naive immigrant population: influence of infection duration, infection intensity, and host age.

Naus CW, Kimani G, Ouma JH, Fulford AJ, Webster M, van Dam GJ, Deelder AM, Butterworth AE, Dunne DW.

Infect Immun. 1999 Jul;67(7):3444-51.

42.

Adult resistance to schistosomiasis mansoni: age-dependence of reinfection remains constant in communities with diverse exposure patterns.

Kabatereine NB, Vennervald BJ, Ouma JH, Kemijumbi J, Butterworth AE, Dunne DW, Fulford AJ.

Parasitology. 1999 Jan;118 ( Pt 1):101-5.

PMID:
10070667
43.

Immunological aspects of human schistosomiasis.

Butterworth AE.

Br Med Bull. 1998;54(2):357-68. Review.

PMID:
9830202
44.

The development of schistosomiasis mansoni in an immunologically naive immigrant population in Masongaleni, Kenya.

Ouma JH, Fulford AJ, Kariuki HC, Kimani G, Sturrock RF, Muchemi G, Butterworth AE, Dunne DW.

Parasitology. 1998 Aug;117 ( Pt 2):123-32.

PMID:
9778634
45.

High levels of TNF, soluble TNF receptors, soluble ICAM-1, and IFN-gamma, but low levels of IL-5, are associated with hepatosplenic disease in human schistosomiasis mansoni.

Mwatha JK, Kimani G, Kamau T, Mbugua GG, Ouma JH, Mumo J, Fulford AJ, Jones FM, Butterworth AE, Roberts MB, Dunne DW.

J Immunol. 1998 Feb 15;160(4):1992-9.

46.

Effect of praziquantel and oxamniquine treatment on human isotype responses to Schistosoma mansoni: elevated IgE to adult worm.

Webster M, Fallon PG, Fulford AJ, Butterworth AE, Ouma JH, Kimani G, Dunne DW.

Parasite Immunol. 1997 Jul;19(7):333-5.

47.

Schistosoma mansoni: maturation rate and drug susceptibility of different geographic isolates.

Fallon PG, Mubarak JS, Fookes RE, Niang M, Butterworth AE, Sturrock RF, Doenhoff MJ.

Exp Parasitol. 1997 May;86(1):29-36.

PMID:
9149238
48.

The influence of sex and age on antibody isotype responses to Schistosoma mansoni and Schistosoma japonicum in human populations in Kenya and the Philippines.

Webster M, Libranda-Ramirez BD, Aligui GD, Olveda RM, Ouma JH, Kariuki HC, Kimani G, Olds GR, Fulford AJ, Butterworth AE, Dunne DW.

Parasitology. 1997 Apr;114 ( Pt 4):383-93.

PMID:
9107025
49.

Spatial patterns of human water contact and Schistosoma mansoni transmission and infection in four rural areas in Machakos District, Kenya.

Kloos H, Fulford AJ, Butterworth AE, Sturrock RF, Ouma JH, Kariuki HC, Thiongo FW, Dalton PR, Klumpp RK.

Soc Sci Med. 1997 Apr;44(7):949-68.

PMID:
9089917
50.

IgG4 and IgE responses to Schistosoma mansoni adult worms after treatment.

Webster M, Fallon PG, Fulford AJ, Butterworth AE, Ouma JH, Kimani G, Dunne DW.

J Infect Dis. 1997 Feb;175(2):493-4. No abstract available.

PMID:
9203682

Supplemental Content

Loading ...
Support Center